Clinical Trial Update: Sildenafil To Prevent Clot [EARLY_Phase 1]

View source ↗

Summary

A Phase I study evaluating sildenafil for prevention of clotting in thrombosis and hemolysis has completed and results were posted in July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolysis
• Thrombosis

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Thrombosis, Hemolysis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-07-10